Charles River Laboratories International (CRL) Total Liabilities (2009 - 2025)

Charles River Laboratories International's Total Liabilities history runs 17 years deep, the most recent figure standing at $3.9 billion for Q4 2025.

• In Q4 2025, Total Liabilities fell 2.39% year-over-year to $3.9 billion; the TTM figure through Dec 2025 stood at $3.9 billion (down 2.39% YoY), while the FY2025 annual figure was $3.9 billion, down 2.39% from the prior year.
• Total Liabilities for Q4 2025 stood at $3.9 billion, down from $4.1 billion in the prior quarter.
• The five-year high for Total Liabilities was $4.8 billion in Q2 2022, with the low at $3.6 billion in Q1 2021.
• The 5-year median for Total Liabilities is $4.4 billion (2021), against an average of $4.3 billion.
• The sharpest annual moves came in 2021 and 2024: Total Liabilities surged 32.42% in 2021, then retreated 11.37% in 2024.
• Charles River Laboratories International's Total Liabilities stood at $4.4 billion in 2021, then rose by 3.32% to $4.6 billion in 2022, then declined by 0.94% to $4.5 billion in 2023, then fell by 11.37% to $4.0 billion in 2024, then slipped by 2.39% to $3.9 billion in 2025.
• Business Quant data shows CRL's Total Liabilities at $3.9 billion in Q4 2025, $4.1 billion in Q3 2025, and $4.2 billion in Q2 2025.